134 related articles for article (PubMed ID: 32914346)
1. Effect of the dipeptidyl peptidase-4 inhibitor linagliptin on atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits: iMap-IVUS and pathological analysis.
Kurosawa T; Li Y; Sudo M; Haruta H; Hagikura K; Takayama T; Hiro T; Shiomi M; Hao H; Matsumoto T; Hirayama A; Okumura Y
Heart Vessels; 2021 Jan; 36(1):127-135. PubMed ID: 32914346
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits.
Sudo M; Li Y; Hiro T; Takayama T; Mitsumata M; Shiomi M; Sugitani M; Matsumoto T; Hao H; Hirayama A
Atherosclerosis; 2017 Oct; 265():283-291. PubMed ID: 28693828
[TBL] [Abstract][Full Text] [Related]
3. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
Virta J; Hellberg S; Liljenbäck H; Ståhle M; Silvola JMU; Huusko J; Söderström M; Knuuti J; Nuutila P; Ylä-Herttuala S; Gomez MF; Roivainen A; Saraste A
Atherosclerosis; 2020 Jul; 305():64-72. PubMed ID: 32386751
[TBL] [Abstract][Full Text] [Related]
4. Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound.
Iwata A; Miura S; Imaizumi S; Zhang B; Saku K
J Cardiol; 2007 Oct; 50(4):229-34. PubMed ID: 17987838
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study.
Haruta H; Hiro T; Mitsumata M; Takayama T; Sudo M; Li Y; Takahashi R; Taniguchi Y; Shiomi M; Hirayama A
J Cardiol; 2016 Feb; 67(2):205-11. PubMed ID: 26194868
[TBL] [Abstract][Full Text] [Related]
6. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
[TBL] [Abstract][Full Text] [Related]
7. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
Yamaguchi T; Watanabe A; Tanaka M; Shiota M; Osada-Oka M; Sano S; Yoshiyama M; Miura K; Kitajima S; Matsunaga S; Tomita S; Iwao H; Izumi Y
J Pharmacol Sci; 2019 Feb; 139(2):112-119. PubMed ID: 30638989
[TBL] [Abstract][Full Text] [Related]
8. Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study.
Nozue T; Fukui K; Koyama Y; Fujii H; Kunishima T; Hikita H; Hibi K; Miyazawa A; Michishita I
Heart Vessels; 2016 May; 31(5):649-54. PubMed ID: 25794984
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of inflammation-mediated DPP-4 expression by linagliptin increases M2 macrophages in atherosclerotic lesions.
Nishida S; Matsumura T; Senokuchi T; Murakami-Nishida S; Ishii N; Morita Y; Yagi Y; Motoshima H; Kondo T; Araki E
Biochem Biophys Res Commun; 2020 Mar; 524(1):8-15. PubMed ID: 31964532
[TBL] [Abstract][Full Text] [Related]
10. Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits.
Iwata A; Miura S; Zhang B; Imaizumi S; Uehara Y; Shiomi M; Saku K
Atherosclerosis; 2011 Oct; 218(2):300-7. PubMed ID: 21696737
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2016 Apr; 79():16-23. PubMed ID: 26277250
[TBL] [Abstract][Full Text] [Related]
12. Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes.
Klein T; Tammen H; Mark M; Benetti E; Delić D; Schepers C; von Eynatten M
Diabetes Obes Metab; 2021 Aug; 23(8):1968-1972. PubMed ID: 33881796
[TBL] [Abstract][Full Text] [Related]
13. Visualization of coronary plaque in type 2 diabetes mellitus patients using a new 40 MHz intravascular ultrasound imaging system.
Araki T; Nakamura M; Utsunomiya M; Sugi K
J Cardiol; 2012 Jan; 59(1):42-9. PubMed ID: 21890326
[TBL] [Abstract][Full Text] [Related]
14. Significance of vascular dipeptidyl peptidase-4 inhibition on vascular protection in Zucker diabetic fatty rats.
Takai S; Sakonjo H; Jin D
J Pharmacol Sci; 2014; 125(4):386-93. PubMed ID: 25030743
[TBL] [Abstract][Full Text] [Related]
15. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice.
Nakaoku Y; Saito S; Yamamoto Y; Maki T; Takahashi R; Ihara M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126115
[TBL] [Abstract][Full Text] [Related]
16. DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization.
Zhuge F; Ni Y; Nagashimada M; Nagata N; Xu L; Mukaida N; Kaneko S; Ota T
Diabetes; 2016 Oct; 65(10):2966-79. PubMed ID: 27445264
[TBL] [Abstract][Full Text] [Related]
17. Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study.
Souza CF; Maehara A; Mintz GS; Matsumura M; Alves CMR; Carlos Carvalho A; Caixeta A
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1107-1114. PubMed ID: 28191713
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerotic plaque identification by virtual histology intravascular ultrasound in a rabbit abdominal aorta model of vulnerable plaque.
Lin QF; Luo YK; Zhao ZW; Cai W; Zhen XC; Chen LL
Exp Biol Med (Maywood); 2013 Nov; 238(11):1223-32. PubMed ID: 24085783
[TBL] [Abstract][Full Text] [Related]
19. [Intravascular ultrasound with virtual histology in assessment of atherosclerotic plaque composition in patients with coronary artery disease and type 2 diabetes mellitus].
Zakharov AS; Michurova MS; Terekhin SA; Kalashnikov VY; Smirnova OM; Shestakova MV; Dedov II
Ter Arkh; 2019 Dec; 91(12):41-46. PubMed ID: 32598588
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy.
Sharkovska Y; Reichetzeder C; Alter M; Tsuprykov O; Bachmann S; Secher T; Klein T; Hocher B
J Hypertens; 2014 Nov; 32(11):2211-23; discussion 2223. PubMed ID: 25215436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
